Anixter International Inc. (AXE) Broke Out To A New High After Q4 Report

Anixter International Inc. (AXE) reported fourth quarter EPS of $1.31 Tuesday morning, up from $1.05 in the prior year period.

from RTT - Before the Bell http://ift.tt/2jUlUUk
via IFTTT

Read More »

Danaher Corp. (DHR) Climbed To A 6-Month High After Q4 Profit Beat

Danaher Corp. (DHR) reported fourth quarter EPS of $1.05 Tuesday morning, compared to $0.91 in the prior year. The consensus estimate was for EPS of $1.03.

from RTT - Before the Bell http://ift.tt/2jWq9RJ
via IFTTT

Read More »

Sanmina Corp. (SANM) Set A New High On Better Than Expected Q1 Earnings

Sanmina Corp. (SANM) reported first quarter EPS of $0.75 after the bell Monday, up from $0.58 last year. Analysts expected EPS of $0.67.

from RTT - Before the Bell http://ift.tt/2kUJhwR
via IFTTT

Read More »

Ally Financial Inc. (ALLY) Leaped To A New High On Strong Q4 Results

Ally Financial Inc. (ALLY) reported fourth quarter adjusted EPS of $0.54 Tuesday morning, which topped the consensus estimate of $0.47.

from RTT - Before the Bell http://ift.tt/2kUvMgK
via IFTTT

Read More »

Momenta Pharmaceuticals Inc. (MNTA) Surged To A New High On Patent Ruling

Momenta Pharmaceuticals Inc. (MNTA) announced Tuesday morning that the U.S. District Court for the District of Delaware invalidated Teva Pharmaceuticals' (TEVA) patents for COPAXONE.

from RTT - Before the Bell http://ift.tt/2krf6k7
via IFTTT

Read More »

Electrolux Turns To Profit In Q4; Organic Sales, Latin America Weak; Stock Dips

Swedish home appliances giant Electrolux AB reported Wednesday a profit in its fourth quarter, compared to loss last year, despite weak Latin American results and nearly flat European sales. On an organic basis, sales declined. The company also proposed a higher dividend for the year 2016.

from RTT - Earnings http://ift.tt/2jVnV4V
via IFTTT

Read More »

Gainers & Losers Of The Day: MNTA, BLCM, VSAR, TENX, DMTX...

Tenax Therapeutics Inc. lost more than 76% of its stock value, following the failure of its phase III LEVO-CTS trial.

from RTT - Biotech http://ift.tt/2kpTDYQ
via IFTTT

Read More »